Candriam SCA’s Covista Inc CVSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,591
Closed -$414K 684
2026
Q1
$414K Sell
3,591
-885
-20% -$94.5K ﹤0.01% 665
2025
Q4
$463K Hold
4,476
﹤0.01% 647
2025
Q3
$691K Sell
4,476
-58,465
-93% -$7.49M ﹤0.01% 602
2025
Q2
$8.01M Buy
62,941
+2,453
+4% +$290K 0.05% 286
2025
Q1
$6.09M Buy
60,488
+43,488
+256% +$4.34M 0.04% 294
2024
Q4
$1.54M Hold
17,000
0.01% 535
2024
Q3
$1.28M Hold
17,000
0.01% 555
2024
Q2
$1.16M Hold
17,000
0.01% 553
2024
Q1
$874K Buy
+17,000
New +$888K 0.01% 609
2019
Q3
Sell
-8,000
Closed -$359K 746
2019
Q2
$359K Hold
8,000
﹤0.01% 772
2019
Q1
$371K Hold
8,000
﹤0.01% 749
2018
Q4
$379K Buy
+8,000
New +$409K 0.01% 723

Other funds holding CVSA

Candriam SCA's CVSA Position: Q2 2026 in Review

Candriam SCA sold out of Covista Inc (CVSA) in Q2 2026, closing a stake of 3,591 shares — an estimated $414K sold.

Candriam SCA first reported a position in CVSA in Q4 2018 and held it in 12 quarters. The position peaked at $8.01M in Q2 2025. 378 funds tracked by Wall St. Rank hold CVSA as of Q2 2026.

  • Candriam SCA reported no remaining Covista Inc position as of Q2 2026 after selling out during the quarter.
  • Candriam SCA sold 3,591 Covista Inc shares in Q2 2026, an estimated $414K.
  • Candriam SCA first reported a position in Covista Inc in Q4 2018 and held it in 12 quarters.
  • Candriam SCA's Covista Inc position peaked at $8.01M in Q2 2025.
  • 378 funds tracked by Wall St. Rank held Covista Inc as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.